HOME >> MEDICINE >> NEWS
Sprinklers shown effective in slowing dorm fires

An automatic sprinkler system significantly increases a person's chances of surviving a dormitory fire, according to a report issued recently by the National Institute of Standards and Technology (NIST).

Three NIST experiments,* supported by a U.S. Fire Administration (USFA) initiative for fire safety in college housing, compared the hazards of fires in smoke detector-equipped dormitories with and without fire sprinklers in the room of fire origin. Researchers started fires in a day room or lounge area open to the corridor of a dormitory. They used the temperature of 120 degrees C (248 degrees F) as the cutoff mark for human survival. For comparison, the temperature of boiling water is 100 degrees C.

In two experiments without sprinklers, potentially fatal temperatures exceeding 120 degrees C as well as toxic gases reached a remote corridor 22.9 meters (75 feet) away within three minutes and completely spread throughout the corridor within another three minutes. In an experiment with sprinklers, temperatures at the 1.5 meter (five feet) level and below in the room where the fire began never exceeded 120 degrees C. No significant increase in heat was measured in the corridor during the experiment, allowing adequate time for residents to escape.

NIST conducted the experiments at a barracks donated by the Myrtle Beach Air Force Base Redevelopment Authority in Myrtle Beach, S.C. The USFA incorporated footage of NIST sprinkler tests into a fire safety video for college administrators and students.


'"/>

Contact: John Blair
john.blair@nist.gov
301-975-4261
National Institute of Standards and Technology (NIST)
11-Feb-2005


Page: 1

Related medicine news :

1. Cartilage repair techniques shown to restore patient mobility and reduce pain
2. Controversial drug shown to act on brain protein to cut alcohol use
3. HPV vaccine shown effective at reducing cancer-causing infections
4. HPV vaccine shown to substantially reduce cervical cancer
5. New research results: Heart jacket shown to be effective
6. Pioglitazone shown to reverse thickening of carotid artery wall
7. Isolated soy protein shown to benefit type 2 diabetics, study indicates
8. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
9. Increased risk of cardiovascular disease shown in PCOS patients
10. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
11. Anti-eosinophil therapy shown to be effective in treating hypereosinophilic syndrome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology:
Cached News: